Islet cell transplant trial aims to free diabetics from insulin shots
NCT ID NCT00160732
First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 20 times
Summary
This study tests the safety of transplanting donor islet cells into people with difficult-to-control type 1 diabetes. The goal is to see if the cells can help stabilize blood sugar and reduce the need for insulin injections. Participants also receive anti-rejection drugs to protect the transplanted cells, but must take these medications long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The University of Chicago Hospitals
Chicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.